Gkv Capital Management Co., Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Gkv Capital Management Co., Inc.
- $245 Billion
- Q4 2024
A detailed history of Gkv Capital Management Co., Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gkv Capital Management Co., Inc. holds 3,835 shares of REGN stock, worth $2.58 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
3,835Holding current value
$2.58 Million% of portfolio
1.11%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,485Shares Held
84.8MCall Options Held
1.51MPut Options Held
1.48M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.26 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.69 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.76 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.25 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.19 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...